Skip to content
10-Q

Quarterly Report

TRACON Pharmaceuticals, Inc.

0000950170-24-096403

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 8, 2024 3.41M sh
Shares Diluted Q2 2024 · Jun 30, 2024 3.01M sh
Shares Diluted Q2 2024 · Jun 30, 2024 2.7M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 1.6M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 1.43M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$5.31M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$10.85M
Short Term Investments Q2 2024 · Jun 30, 2024 $0
Short Term Investments Q2 2024 · Dec 31, 2023 $0
Cash And Equivalents Q2 2024 · Jun 30, 2024 $6.27M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $8.56M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$3.09M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$1.76M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$809K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$15.74M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$11.07M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$7.15M
Current Liabilities Q2 2024 · Jun 30, 2024 $9.89M
Current Liabilities Q2 2024 · Dec 31, 2023 $10.18M
Current Assets Q2 2024 · Jun 30, 2024 $6.51M
Current Assets Q2 2024 · Dec 31, 2023 $9.09M
Total Assets Q2 2024 · Jun 30, 2024 $7.4M
Total Assets Q2 2024 · Dec 31, 2023 $10.11M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.94
Eps Diluted Q2 2024 · Jun 30, 2024 −$2.23
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$3.94
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$10.36
Eps Basic Q2 2024 · Jun 30, 2024 −$0.94
Eps Basic Q2 2024 · Jun 30, 2024 −$2.23
Eps Basic restated Q2 2024 · Jun 30, 2023 −$3.94
Eps Basic restated Q2 2024 · Jun 30, 2023 −$10.36
Sga Expense Q2 2024 · Jun 30, 2024 $1.62M
Sga Expense Q2 2024 · Jun 30, 2024 $3.05M
Sga Expense Q2 2024 · Jun 30, 2023 $1.92M
Sga Expense Q2 2024 · Jun 30, 2023 $4.26M
Rd Expense Q2 2024 · Jun 30, 2024 $1.35M
Rd Expense Q2 2024 · Jun 30, 2024 $3.23M
Rd Expense Q2 2024 · Jun 30, 2023 $3.49M
Rd Expense Q2 2024 · Jun 30, 2023 $8.46M
Net Income Q2 2024 · Jun 30, 2024 −$2.84M
Net Income Q2 2024 · Jun 30, 2024 −$6.01M
Net Income Q2 2024 · Mar 31, 2024 −$3.17M
Net Income Q2 2024 · Jun 30, 2023 −$6.29M
Net Income Q2 2024 · Jun 30, 2023 −$14.79M
Net Income Q2 2024 · Mar 31, 2023 −$8.5M
Operating Income Q2 2024 · Jun 30, 2024 −$2.91M
Operating Income Q2 2024 · Jun 30, 2024 −$6.12M
Operating Income Q2 2024 · Jun 30, 2023 −$779K
Operating Income Q2 2024 · Jun 30, 2023 −$8.09M
Revenue Q2 2024 · Jun 30, 2024 $55K
Revenue Q2 2024 · Jun 30, 2024 $155K
Revenue Q2 2024 · Jun 30, 2023 $9M
Revenue Q2 2024 · Jun 30, 2023 $9M